Markets and Vulnerable Patients: Health Law After the 2012 Act

Victoria Chico, Prof Tamara Hervey, Ruth Stirton, Amanda Warren-Jones

Research output: Contribution to journalEditorial

5 Citations (Scopus)

Abstract

In the popular imagination, the Health and Social Care Act 2012 is associated with a final ‘dismantling of the NHS as we know it’, by bringing competition, markets, contracts, and private interests in to the NHS. The Bill’s turbulent journey through the Parliamentary process shows how controversial such a move was understood to be. This process also took place at a time when, in view of numerous inquiries, public trust in the ability of English healthcare institutions
(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legal
scholars;, and regulation specialists to consider key issues raised by the Act.
Original languageEnglish
Pages (from-to)157-161
Number of pages5
JournalMedical Law Review
Volume22
Issue numberSpecial Issue: 2
DOIs
Publication statusPublished - 1 Jun 2014
Externally publishedYes

Fingerprint Dive into the research topics of 'Markets and Vulnerable Patients: Health Law After the 2012 Act'. Together they form a unique fingerprint.

  • Cite this